Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. - Wikidata - awgldk - TriplyDB

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

http://www.wikidata.org/entity/Q34698821

about

BRCA1 is an essential regulator of heart function and survival following myocardial infarction Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice Stimulating endogenous cardiac repair Programming and reprogramming a human heart cell Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy Cell-based interventions for therapeutic angiogenesis: review of potential cell sources Origin of cardiomyocytes in the adult heart Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications Bone marrow SSEA1+ cells support the myocardium in cardiac pressure overload Left atrial appendages from adult hearts contain a reservoir of diverse cardiac progenitor cells Regenerating functional heart tissue for myocardial repair Immune Modulation of Cardiac Repair and Regeneration: The Art of Mending Broken Hearts Developmental origin and lineage plasticity of endogenous cardiac stem cells Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth Working hypothesis to redefine endothelial progenitor cells Endothelial progenitor cells: identity defined?Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice c-kit is required for cardiomyocyte terminal differentiation Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Proliferation of mouse embryonic stem cell progeny and the spontaneous contractile activity of cardiomyocytes are affected by microtopography Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.Targeted cell replacement with bone marrow cells for airway epithelial regeneration.Cell therapy in congestive heart failure.Bone marrow cells adopt the cardiomyogenic fate in vivo.Lineage tracing of cardiac explant derived cells.Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium.Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.Cell fusion of bone marrow cells and somatic cell reprogramming by embryonic stem cells.Sorafenib cardiotoxicity increases mortality after myocardial infarction.Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms

P2860

Q24300290-FE321A54-BAC5-43D8-A0DA-91D185086444 Q24632487-99C1DE04-CF6C-49FA-94A8-6DE0EC75246F Q26781323-B1857A56-FE5D-4889-AFBD-93EC907ABBF3 Q26823933-66EB1BCC-B9FD-4880-8032-7374A6D6379E Q26825272-D25BE172-1149-4B9A-8DE7-2F5E0900ADEE Q27022590-2D300B30-A98B-4EB7-AFD0-558ACB35B522 Q27023325-9DBF1995-7707-472D-B121-E31A1F6014E2 Q27025843-85D35BAD-B48B-488B-96FF-420570BE69EB Q27025973-B8206769-F918-415A-9510-E6B1DAA6B81F Q27311423-AB1270EE-9C1F-4513-A6AF-8EEE521C5244 Q27334201-C7EC62D4-CD98-4CD2-90F3-D66732EC1C6B Q27687840-3D97121E-533D-41BC-9E1E-74175CB2FFEA Q28070004-795C949B-43D0-45F6-93EB-EE48EDB73089 Q28080127-401AEAFB-AA79-46D5-8613-8AB968C9AD96 Q28278074-819AC391-DA69-4F3C-91A0-FEB8FFF77D12 Q28295515-F2054CB1-CFE7-4705-9BBE-ECA51EEE893D Q28303395-851C2C2A-D72A-4CD5-AA59-064F9977BC95 Q28576883-EF47F9C4-70D8-464D-9276-95CA968F9657 Q28587325-4968192E-E559-4B68-967C-3D65D0A8A96A Q28591940-090B6DDE-F06D-4AF6-BC25-0DD910B4BA81 Q28595050-90CEC404-8F84-4DA1-B459-D9880CED121E Q30396728-07C7A196-600C-4B85-B2D6-66D56F4701B4 Q30426853-81A31CAD-8C57-48C9-9B9C-31501416D966 Q30541635-22EC0BF3-DA8A-4089-BBB5-A40E73EC5E2D Q30575719-DD791F03-19F1-4245-9E54-2F5A3DA7B80A Q33290207-3940C5D2-5231-4DAD-B5B9-C985E4AF93C5 Q33295408-32CECBC7-AC9A-4271-AB3F-D58DA904D995 Q33304156-554CE14A-7917-477C-80A2-51F5A69A378C Q33328467-29D0DF50-0955-40EF-B0C8-9578DC204D50 Q33330259-09FFBF38-0AFC-4668-A329-0694C5A4BA0A Q33340205-45F00CCF-5685-42A5-8DD3-3FC71DDC269E Q33379564-DA3DD225-6346-4D80-BB97-E861CF5115DD Q33490304-DB4B8EF7-FE92-457E-BCAA-C6F5172A8E30 Q33613197-8583310D-51A3-4D9F-B43D-B4CDCE922DF5 Q33681995-5503A202-D953-4D9A-85C8-75A8FCF1EFB1 Q33690013-4E3AEBA0-10FB-4A10-BA47-E15F5B9A489F Q33698419-B39C6F36-1DC9-49BA-A93E-B043B4B552D4 Q33699411-C5644699-3B50-4F25-9B56-4F7A2DA89D57 Q33745962-40CE652C-A814-462B-A2D0-2A0B37912271 Q33746675-F522BD0E-B97C-4196-A1CC-E837283CC7A9

P2860

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

http://www.wikidata.org/entity/Q34698821

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@ast

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@en

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@nl

type

label

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@ast

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@en

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@nl

prefLabel

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@ast

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@en

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@nl

P1433

Q34698821-1EA0BE6F-BEED-4224-A01E-BCA4F58F83FD

P1476

Q34698821-780EF279-84E9-4EEB-943D-D6A98AA35C54

P2093

Q34698821-0DBD5A4A-0F42-4BA4-AD2D-2AA65EF98839

Q34698821-20320390-DF8A-4DE6-B912-A2F5C907E240

Q34698821-6739512C-7515-413B-A271-E8BE117821E4

Q34698821-6C24C451-74BC-4E87-A3ED-313DC8DD8946

Q34698821-A3AD6D1D-0092-449C-955D-8B41A385CDC9

Q34698821-B6D80066-010E-435F-A221-A8E2D520C51E

Q34698821-C640E4E9-E108-4FD1-9ECC-D748F059922A

Q34698821-C6FAE4F7-BC97-4E07-AE8B-C36FFAA09C0C

Q34698821-D96EA628-EA7A-4A0C-AD6B-82365590D433

Q34698821-EE407116-76A2-463C-8530-E5FEAB031F33

P2860

Q34698821-02EACEF3-E386-489C-8396-319F1A2C241C

Q34698821-0C193516-4367-497C-AF22-A67CEF250F19

Q34698821-137056AA-5DF2-474C-AE3A-E3CC9FA74BE7

Q34698821-150FA9EA-8A17-404B-ACCE-E9F949A27B17

Q34698821-18C088B0-A022-40F2-995D-727EB1EED491

Q34698821-1B7CF646-ECE1-43B2-A5B5-5A8A7AD67DAB

Q34698821-20DFB9E6-E08B-4B5A-8F51-368BAC4E491B

Q34698821-2146F6D7-05AF-4B79-AFF4-504E054E91BB

Q34698821-22983454-7D68-41C9-8C3D-5773BE9C66BF

Q34698821-2B647477-56F5-4D0A-8845-BF21A6411A2C

P304

Q34698821-52869505-970C-410B-93BC-BEE51E9351B6

P31

Q34698821-D82A1D3F-E327-460D-9BE3-F21FD0957AA2

P356

Q34698821-5A112126-7281-44FA-B0C9-79567CF31D10

P407

Q34698821-70E06DAC-A8DF-4565-903A-CA95A8183FC1

P433

Q34698821-AE1D1C0B-C03B-48DB-B76F-D07EDB245309

P478

Q34698821-E8746AE9-3D7E-4F27-B904-D6AB4B1561C4

P577

Q34698821-872351B9-65E0-460E-A152-0DE22718ECF4

P698

Q34698821-567BDDF9-117A-4FC4-B738-A849E5ED5E6E

P921

Q34698821-E938CD1B-F1C5-4149-A2E3-6DA4573A6EDD

P932

Q34698821-188E62AB-8DB6-49B0-9F96-05209441215A

P356

P1433

Journal of Clinical Investigation

P1476

Cardioprotective c-kit+ cells ...... lance of angiogenic cytokines.

@en

P2093

Armand Keating

http://www.w3.org/2001/XMLSchema#string

Denis Angoulvant

http://www.w3.org/2001/XMLSchema#string

Liwen Chen

http://www.w3.org/2001/XMLSchema#string

Massimo Cimini

http://www.w3.org/2001/XMLSchema#string

Paul Fedak

http://www.w3.org/2001/XMLSchema#string

Ren-Ke Li

http://www.w3.org/2001/XMLSchema#string

Richard D Weisel

http://www.w3.org/2001/XMLSchema#string

Shafie Fazel

http://www.w3.org/2001/XMLSchema#string

Shuhong Li

http://www.w3.org/2001/XMLSchema#string

Subodh Verma

http://www.w3.org/2001/XMLSchema#string

P2860

CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling

ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

Bone marrow cells regenerate infarcted myocardium

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

Isolation of putative progenitor endothelial cells for angiogenesis

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Adult cardiac stem cells are multipotent and support myocardial regeneration

P304

1865-1877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI27019

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16823487

http://www.w3.org/2001/XMLSchema#string

P921

P932

1483161

http://www.w3.org/2001/XMLSchema#string